MarginsXMarginsX
Home › Canada › TSXV stocks › DHB

Delivra Health Brands Inc. (TSXV: DHB)

DHB trades on the TSX Venture Exchange in Life Sciences, headquartered in British Columbia. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.

Close · November 13, 2026
C$0.0900
0.00% on the day
Market cap (C$)
C$2.3M
TMX list, October 31, 2026
Market cap (US$)
US$1.6M
Nano cap at 1.4257 C$/US$
1-year return
-70.5%
-56.1% year to date

Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of October 31, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for DHB.V, last bar 2026-11-13, computed by MarginsX.

Profile

FieldValue
TickerDHB on the TSX Venture Exchange
Yahoo symbolDHB.V
SectorLife Sciences, Cannabis
HeadquartersBritish Columbia
Listed2017-04-28
Listing typeQT from NEX
Shares outstanding31,261,781
Also listed onNo interlisting on the TMX list
Index membershipNot in an S&P/TSX index per the TMX list
SEC CIKNo SEC filer matched on exact name with a Canadian address or US interlisting
WebsiteNo company website on record

Returns

WindowReturn
1 day0.0%
1 week+12.5%
1 month+5.9%
3 months-10.0%
6 months-30.8%
Year to date-56.1%
1 year-70.5%
From 52-week high-70.0%
52-week rangeC$0.0750 to C$0.3000

Links

SEDAR+ is linked for searching only; nothing on this page is taken from it.

Recent Canadian filings by type

110 documents in 6 types. Each title links to the document at its source.

Annual financial statements (7)

DocumentTypeFiled
Year End 2018 Financials Statements 876kb
Period Year ended June 30, 2018
Annual financial statements2026-02-28
Financial Statements - for the year ending June 30, 2023 600kb
Period 2023-09-30
Annual financial statements2023-06-30
Year End 2022 Financial Statements 4.8mb
Period 2022-09-30
Annual financial statements2022-09-30
Year End 2021 Financial Statements 628kb
Period 2021-09-30
Annual financial statements2021-09-30

Interim financial statements (27)

DocumentTypeFiled
Financial Statements - For the three and nine months ended March 31, 2026 623kb
Period Q3 2026
Interim financial statements2026-03-31
Financial Statements - For the three and six months ended December 31, 2025 622kb
Period 2025-12-31
Interim financial statements2025-12-31
Financial Statements - For the three months ended September 30th, 2025 570kb
Period 2025-12-31
Interim financial statements2025-09-30
Financial Statements - For the three and nine months ended March 31, 2025 661kb
Period Q3 2025
Interim financial statements2025-03-31

MD&A (37)

News release (3)

Management information circular / proxy (25)

DocumentTypeFiled
2020 Notice of Meeting and Information Circular 1.7mb
Period FY2020
Management information circularNo date
2022 AGM Circular 1871kbManagement information circularNo date
2021 AGM Circular 288kbManagement information circularNo date
2023 AGM Circular 416kbManagement information circularNo date

Other (11)

DocumentTypeFiled
FactsheetInvestor presentationNo date
Investor PresentationInvestor presentationNo date
Financial Statements - For the year ending June 30, 2026 1.5mbFinancial statements (period not stated)2026-06-30
Financial Statements - For the year ending June 30th, 2025 670kbFinancial statements (period not stated)2025-06-30

Sources: Company investor-relations website (links only, documents not copied). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.

Trading halts

No CIRO halt notices for this company in our data.

Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.

Upcoming events

No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.

Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.

Peers in Life Sciences

TickerCompanyExchangeMarket cap (C$)1 month1 year
ZCTZero Candida Technologies Inc.TSXVC$2.2M-4.5%-56.3%
THRMTherma Bright Inc.TSXVC$2.0M-28.6%-68.8%
EKGCardioComm Solutions Inc.TSXVC$2.0M0.0%0.0%
AJAAja Health and Wellness Inc.TSXVC$3.0M0.0%0.0%
QPTQuest Pharmatech Inc.TSXVC$3.4M0.0%-50.0%

The app has the price chart, every filing, private raises and the full peer set for DHB.

Open in the app